Biography and Research Information
OverviewAI-generated summary
Jose Ricardo Lopez Castellanos' research focuses on neurological disorders and their treatments, as well as medical education. He has published work evaluating the impact of online resources on the neurology residency application cycle. His clinical research includes case reports on the therapeutic effects of OnabotulinumtoxinA for conditions such as harlequin syndrome, episodic migraine, and piriformis syndrome. Additionally, he has investigated its use in complete symptom remission for Lance-Adams syndrome. His work highlights the application of treatments like OnabotulinumtoxinA in specific neurological and pain-related conditions, alongside an interest in the dynamics of medical education and professional networking within the field.
Metrics
- Publications: 4
Selected Publications
-
#HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125) (2021)
-
Complete remission of symptoms in a case of Lance-Adams syndrome: A 17-year follow-up (2021)
-
Therapeutic effect of OnabotulinumtoxinA in harlequin syndrome and episodic migraine: A case report (2021)
-
Therapeutic effect of onabotulinumtoxina (BONT/A) in piriformis syndrome resistant to conventional therapy (2021)
Collaboration Network
Top Collaborators
- Therapeutic effect of onabotulinumtoxina (BONT/A) in piriformis syndrome resistant to conventional therapy
- Therapeutic effect of OnabotulinumtoxinA in harlequin syndrome and episodic migraine: A case report
- Complete remission of symptoms in a case of Lance-Adams syndrome: A 17-year follow-up
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
Similar Researchers
Based on overlapping research topics